News
0
Novartis’ IL-17A inhibitor has chalked up approval from the European Commission (EC) for the treatment of patients between the ages of six and 18...
0
The EU has reached an agreement with Sanofi for 300 million doses of their COVID-19 vaccine candidate which will allow the trading bloc’s members to...
0
Two new coronavirus tests are set to be made available throughout England that are significantly faster than most already in use.
0
FDA gives nod for Monjuvi combo for second-line relapsed or refractory diffuse large B-cell lymphoma
The FDA has awarded MorphoSys and Incyte US approval for their Fc-modified cytolytic CD19-targeting monoclonal antibody Monjuvi (tafasitamab-cxix),...
Features
CAR T cell therapy, while a revolutionary and life-saving technology, is extremely expensive and is not guaranteed to work, meaning that American...
Featured Appointment
Rhythm Pharmaceuticals have appointed David Meeker, M.D., as its Chief Executive Officer and President of the company.
Meeker succeeds...
Service Company News
Featured Event
17/11/2020 - 18/11/2020 -
Online,
@Pharmafocus
